$YBGJ
Yubo International Biotech Ltd

2023 Q3 Form 10-Q Financial Statement

#000164033423001530 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $428.5K $1.430K
YoY Change 2839.03% -82.06%
Cost Of Revenue $84.43K $545.00
YoY Change 1595.34% -74.28%
Gross Profit $344.1K $885.00
YoY Change 3484.19% -84.87%
Gross Profit Margin 80.3% 61.89%
Selling, General & Admin $275.9K
YoY Change 21.97%
% of Gross Profit 80.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $65.39K $15.51K
YoY Change 1138.45% 193.79%
% of Gross Profit 19.0% 1752.77%
Operating Expenses $337.7K $368.2K
YoY Change 36.22% -25.98%
Operating Profit $6.423K -$367.3K
YoY Change -102.7% -25.27%
Interest Expense $130.00 $51.00
YoY Change -23.53% -185.0%
% of Operating Profit 2.02%
Other Income/Expense, Net $14.71K $148.5K
YoY Change 8351.72% -251713.56%
Pretax Income $6.293K -$367.3K
YoY Change -102.64% -174.73%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $6.293K -$367.3K
YoY Change -102.64% -25.27%
Net Earnings / Revenue 1.47% -25687.2%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 119.8M shares 119.8M shares
Diluted Shares Outstanding 119.8M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.300K
YoY Change -94.11%
Cash & Equivalents $5.295K $5.298K
Short-Term Investments
Other Short-Term Assets $171.3K
YoY Change -23.61%
Inventory $209.7K $212.1K
Prepaid Expenses $171.3K $154.7K
Receivables $48.51K
Other Receivables $277.4K
Total Short-Term Assets $712.3K $700.6K
YoY Change -8.42% -23.85%
LONG-TERM ASSETS
Property, Plant & Equipment $528.3K $523.8K
YoY Change -9.95% -14.61%
Goodwill
YoY Change
Intangibles $55.59K $58.74K
YoY Change -18.85% 78.73%
Long-Term Investments
YoY Change
Other Assets $116.9K
YoY Change 41.32%
Total Long-Term Assets $1.192M $1.261M
YoY Change -59.5% -59.73%
TOTAL ASSETS
Total Short-Term Assets $712.3K $700.6K
Total Long-Term Assets $1.192M $1.261M
Total Assets $1.904M $1.961M
YoY Change -48.82% -51.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $547.4K
YoY Change -19.98%
Accrued Expenses $351.3K
YoY Change -55.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.865M $2.949M
YoY Change -3.53% -20.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $139.5K
YoY Change -90.09%
Total Long-Term Liabilities $139.5K
YoY Change -90.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.865M $2.949M
Total Long-Term Liabilities $139.5K
Total Liabilities $3.005M $3.112M
YoY Change -31.36% -41.31%
SHAREHOLDERS EQUITY
Retained Earnings -$4.368M -$4.374M
YoY Change 15.13% 23.02%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.101M -$1.151M
YoY Change
Total Liabilities & Shareholders Equity $1.904M $1.961M
YoY Change -48.82% -51.58%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $6.293K -$367.3K
YoY Change -102.64% -25.27%
Depreciation, Depletion And Amortization $65.39K $15.51K
YoY Change 1138.45% 193.79%
Cash From Operating Activities -$148.0K
YoY Change -367.83%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -148.0K
Cash From Investing Activities 0.000
Cash From Financing Activities
Net Change In Cash -148.0K
YoY Change -1056.37%
FREE CASH FLOW
Cash From Operating Activities -$148.0K
Capital Expenditures $0.00
Free Cash Flow -$148.0K
YoY Change -255.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Customer Deposits Current
CustomerDepositsCurrent
400485 usd
CY2023Q2 us-gaap Liabilities
Liabilities
3111952 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2935190 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000895464
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 yubo Occupancy Expense
OccupancyExpense
259275 usd
yubo Lease Term
LeaseTerm
P2Y
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
yubo Other
Other
0 usd
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1 pure
yubo Customers Accounted For Sale Percentage
CustomersAccountedForSalePercentage
0.2341 pure
yubo Customers Accounted For Sale Percentagetwocustomer
CustomersAccountedForSalePercentagetwocustomer
0.4682 pure
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-21320
dei Entity Registrant Name
EntityRegistrantName
YUBO INTERNATIONAL BIOTECH LIMITED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-3074326
dei Entity Address Address Line1
EntityAddressAddressLine1
Room 105
dei Entity Address Address Line2
EntityAddressAddressLine2
Building 5
dei Entity Address Address Line3
EntityAddressAddressLine3
31 Xishiku Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Xicheng District
dei Entity Address Region
EntityAddressRegion
Beijing
dei Entity Address Country
EntityAddressCountry
CN
dei City Area Code
CityAreaCode
040
dei Local Phone Number
LocalPhoneNumber
0677-6010
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
119816343 shares
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18220 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
51932 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
64253 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
322173 usd
CY2022Q4 yubo Due From Related Party
DueFromRelatedParty
293434 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
750012 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
616652 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
67679 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
790499 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
123709 usd
CY2022Q4 us-gaap Assets
Assets
2348551 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
549838 usd
CY2023Q2 yubo Customer Deposits Of Vie Without Recourse
CustomerDepositsOfVieWithoutRecourse
400485 usd
CY2022Q4 yubo Customer Deposits Of Vie Without Recourse
CustomerDepositsOfVieWithoutRecourse
0 usd
CY2022Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
0 usd
CY2023Q2 yubo Advance Customer Deposits Current
AdvanceCustomerDepositsCurrent
423755 usd
CY2022Q4 yubo Advance Customer Deposits Current
AdvanceCustomerDepositsCurrent
459970 usd
CY2023Q2 yubo Due To Related Party
DueToRelatedParty
1318888 usd
CY2022Q4 yubo Due To Related Party
DueToRelatedParty
1113617 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
397490 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
400054 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2948837 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2523479 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
163115 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
390445 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2913924 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2935190 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4374420 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3690426 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
168791 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
70043 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1150619 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-565373 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2348551 usd
CY2023Q2 us-gaap Revenues
Revenues
1430 usd
CY2022Q2 us-gaap Revenues
Revenues
7970 usd
us-gaap Revenues
Revenues
153880 usd
us-gaap Revenues
Revenues
23183 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
545 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2119 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
96839 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9066 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
885 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
5851 usd
us-gaap Gross Profit
GrossProfit
57041 usd
us-gaap Gross Profit
GrossProfit
14117 usd
CY2023Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
0 usd
CY2022Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
4263 usd
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
0 usd
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
8084 usd
CY2023Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
148610 usd
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
145300 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
305420 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
363526 usd
CY2023Q2 us-gaap Occupancy Net
OccupancyNet
52777 usd
CY2022Q2 us-gaap Occupancy Net
OccupancyNet
299217 usd
us-gaap Occupancy Net
OccupancyNet
163594 usd
us-gaap Occupancy Net
OccupancyNet
558492 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3346 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
50424 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15512 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3290 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
22103 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6818 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2810 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1994 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5778 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4045 usd
CY2023Q2 us-gaap Other Expenses
OtherExpenses
148452 usd
CY2022Q2 us-gaap Other Expenses
OtherExpenses
39941 usd
us-gaap Other Expenses
OtherExpenses
243954 usd
us-gaap Other Expenses
OtherExpenses
93163 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
368161 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
497351 usd
us-gaap Operating Expenses
OperatingExpenses
740849 usd
us-gaap Operating Expenses
OperatingExpenses
1084552 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-367276 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-491500 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-683808 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1070435 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
51 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
59 usd
us-gaap Interest Expense
InterestExpense
186 usd
us-gaap Interest Expense
InterestExpense
72 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-51 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-59 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-186 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-72 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-367327 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-491559 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-683994 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1070507 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-367327 usd
us-gaap Net Income Loss
NetIncomeLoss
-1070507 usd
CY2023Q2 yubo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2022Q2 yubo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
yubo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2023Q2 yubo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
119820790 shares
yubo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
118182332 shares
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-367327 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-491559 usd
us-gaap Profit Loss
ProfitLoss
-683994 usd
us-gaap Profit Loss
ProfitLoss
-1070507 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
50 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
98748 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-49927 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-311864 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-491509 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-585246 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1120434 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-565373 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-316667 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
43285 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-838755 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-367327 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
55463 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1150619 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-131198 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-578948 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-49977 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-760123 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-491559 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
50 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1251632 usd
us-gaap Net Income Loss
NetIncomeLoss
-683994 usd
us-gaap Net Income Loss
NetIncomeLoss
-1070507 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27881 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10863 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2532 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16743 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-90410 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
13005 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
110072 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
22386 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
14308 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
95297 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
6095 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
64270 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-141619 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
413059 usd
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
400485 usd
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
0 usd
yubo Increase Decrease In Advances From Prospective Customers Distributors
IncreaseDecreaseInAdvancesFromProspectiveCustomersDistributors
-36215 usd
yubo Increase Decrease In Advances From Prospective Customers Distributors
IncreaseDecreaseInAdvancesFromProspectiveCustomersDistributors
-25748 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
205271 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
493974 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-185594 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33342 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
172672 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-24279 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12922 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9063 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18220 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27517 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5298 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36580 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Interest Paid
InterestPaid
186 usd
us-gaap Interest Paid
InterestPaid
72 usd
yubo Occupancy Expenses
OccupancyExpenses
80340 usd
us-gaap Depreciation
Depreciation
18378 usd
us-gaap Other General Expense
OtherGeneralExpense
7 usd
yubo Occupancy Expenses
OccupancyExpenses
370955 usd
us-gaap Other General Expense
OtherGeneralExpense
33430 usd
yubo Assets And Liabilities Currency Translation
AssetsAndLiabilitiesCurrencyTranslation
1=7.0755
yubo Assets And Liabilities Currency Translation
AssetsAndLiabilitiesCurrencyTranslation
1=6.5277
us-gaap Foreign Currency Transactions Description
ForeignCurrencyTransactionsDescription
1=7.2537
CY2022 us-gaap Foreign Currency Transactions Description
ForeignCurrencyTransactionsDescription
1=6.900 RMB
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5298 usd
CY2023Q2 us-gaap Capital
Capital
2248249 usd
us-gaap Net Income Loss
NetIncomeLoss
-683994 usd
us-gaap Net Income Loss
NetIncomeLoss
-1070507 usd
CY2023Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
212101 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
322173 usd
CY2023Q2 yubo Due From Related Party
DueFromRelatedParty
279126 usd
CY2022Q4 yubo Due From Related Party
DueFromRelatedParty
293434 usd
CY2023Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
330494 usd
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
282681 usd
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
182877 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
323832 usd
CY2023Q2 us-gaap Public Utilities Property Plant And Equipment Net
PublicUtilitiesPropertyPlantAndEquipmentNet
22351 usd
CY2022Q4 us-gaap Public Utilities Property Plant And Equipment Net
PublicUtilitiesPropertyPlantAndEquipmentNet
20343 usd
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
23854 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
28230 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
559576 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
655086 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35793 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38434 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
523783 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
616652 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15512 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3290 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
22103 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6818 usd
CY2023Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
34124 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
35784 usd
CY2023Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
39017 usd
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
41017 usd
CY2023Q2 yubo Patents Acquired From Related Party
PatentsAcquiredFromRelatedParty
10920 usd
CY2022Q4 yubo Patents Acquired From Related Party
PatentsAcquiredFromRelatedParty
11569 usd
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
84061 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
88370 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-25318 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-20691 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
58743 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
67679 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2810 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1994 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5778 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4045 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6610 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
15546 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
15546 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9659 usd
CY2023Q2 yubo Finite Lived Intangible Assets Amortization Expense After Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree
11382 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
58743 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
202206 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
281436 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
101988 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
16998 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
602628 usd
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
560605 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0475 pure
CY2023Q2 yubo Value Of The Future Lease Payments
ValueOfTheFutureLeasePayments
602628 usd
CY2023Q2 yubo Occupancy Expense
OccupancyExpense
52777 usd
CY2022Q2 yubo Occupancy Expense
OccupancyExpense
299217 usd
yubo Occupancy Expense
OccupancyExpense
163594 usd
yubo Occupancy Expense
OccupancyExpense
558492 usd
CY2023Q2 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
423755 usd
CY2022Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
459970 usd
CY2023Q2 yubo Due To Related Party
DueToRelatedParty
1318888 usd
CY2022Q4 yubo Due To Related Party
DueToRelatedParty
1113617 usd
CY2023Q2 yubo Preferred Share Par Or Stated Value Per Share
PreferredShareParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Members Capital
MembersCapital
1454038 usd
CY2021Q2 yubo Description Of Loans Owed To World Precision Medicine
DescriptionOfLoansOwedToWorldPrecisionMedicine
the $819,229 loans owed to World Precision Medicine Technology Inc. were settled by conversion into 1,638,458 shares of Class A common stock at $0.50 per share
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.165 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.25 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1 pure
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
921707 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
763182 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
921707 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
763182 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-170999 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-267609 usd
yubo Net Loss Of Platinum
NetLossOfPlatinum
12474 usd
yubo Net Loss Of Platinum
NetLossOfPlatinum
8232 usd
us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
158525 usd
us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
259394 usd
yubo Other
Other
-17 usd
CY2023Q2 us-gaap Deposits
Deposits
68930 usd
yubo Customers Accounted For Sale Percentagetwocustomer
CustomersAccountedForSalePercentagetwocustomer
0.4682 pure
yubo Customers Accounted For Sale Percentage
CustomersAccountedForSalePercentage
0.2341 pure

Files In Submission

Name View Source Status
0001640334-23-001530-index-headers.html Edgar Link pending
0001640334-23-001530-index.html Edgar Link pending
0001640334-23-001530.txt Edgar Link pending
0001640334-23-001530-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yubo-20230630.xsd Edgar Link pending
yubo_10q.htm Edgar Link pending
yubo_ex311.htm Edgar Link pending
yubo_ex312.htm Edgar Link pending
yubo_ex321.htm Edgar Link pending
yubo_ex322.htm Edgar Link pending
yubo-20230630_def.xml Edgar Link unprocessable
yubo-20230630_lab.xml Edgar Link unprocessable
yubo_10q_htm.xml Edgar Link completed
yubo-20230630_pre.xml Edgar Link unprocessable
yubo-20230630_cal.xml Edgar Link unprocessable